BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9608648)

  • 1. Immunohistochemical localization of microcystin-LR in the liver of mice: a study on the pathogenesis of microcystin-LR-induced hepatotoxicity.
    Yoshida T; Makita Y; Tsutsumi T; Nagata S; Tashiro F; Yoshida F; Sekijima M; Tamura S; Harada T; Maita K; Ueno Y
    Toxicol Pathol; 1998; 26(3):411-8. PubMed ID: 9608648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcystin-LR toxicodynamics, induced pathology, and immunohistochemical localization in livers of blue-green algae exposed rainbow trout (oncorhynchus mykiss).
    Fischer WJ; Hitzfeld BC; Tencalla F; Eriksson JE; Mikhailov A; Dietrich DR
    Toxicol Sci; 2000 Apr; 54(2):365-73. PubMed ID: 10774818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nuclear protein phosphatase activity in mouse hepatocytes by the cyanobacterial toxin microcystin-LR.
    Guzman RE; Solter PF; Runnegar MT
    Toxicon; 2003 Jun; 41(7):773-81. PubMed ID: 12782077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoprotein analysis for investigation of in vivo relationship between protein phosphatase inhibitory activities and acute hepatotoxicity of microcystin-LR.
    Tachi M; Imanishi SY; Harada K
    Environ Toxicol; 2007 Dec; 22(6):620-9. PubMed ID: 18000846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary and hepatic injury after sub-chronic exposure to sublethal doses of microcystin-LR.
    Carvalho GM; Oliveira VR; Casquilho NV; Araujo AC; Soares RM; Azevedo SM; Pires KM; Valença SS; Zin WA
    Toxicon; 2016 Mar; 112():51-8. PubMed ID: 26844922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal administration of microcystin-LR, and its distribution.
    Ito E; Kondo F; Harada K
    Toxicon; 2001; 39(2-3):265-71. PubMed ID: 10978744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sublethal microcystin-LR exposure in mice.
    Guzman RE; Solter PF
    Vet Pathol; 2002 Jan; 39(1):17-26. PubMed ID: 12102214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of protein phosphatase inhibitory activity and apparent toxicity of microcystins and related compounds.
    Ito E; Takai A; Kondo F; Masui H; Imanishi S; Harada K
    Toxicon; 2002 Jul; 40(7):1017-25. PubMed ID: 12076656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intraperitoneally administered microcystin-LR on the gastrointestinal tract of Balb/c mice.
    Botha N; van de Venter M; Downing TG; Shephard EG; Gehringer MM
    Toxicon; 2004 Mar; 43(3):251-4. PubMed ID: 15033322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report on the distribution of orally administered microcystin-LR in mouse tissue using an immunostaining method.
    Ito E; Kondo F; Harada K
    Toxicon; 2000 Jan; 38(1):37-48. PubMed ID: 10669010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic oxidative stress following prolonged sublethal microcystin LR exposure.
    Guzman RE; Solter PF
    Toxicol Pathol; 1999; 27(5):582-8. PubMed ID: 10528638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant hepatocyte apoptosis in vivo following microcystin-LR administration to rats.
    Hooser SB
    Toxicol Pathol; 2000; 28(5):726-33. PubMed ID: 11026609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged exposure to low-dose microcystin induces nonalcoholic steatohepatitis in mice: a systems toxicology study.
    He J; Li G; Chen J; Lin J; Zeng C; Chen J; Deng J; Xie P
    Arch Toxicol; 2017 Jan; 91(1):465-480. PubMed ID: 26984711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged sublethal exposure to the protein phosphatase inhibitor microcystin-LR results in multiple dose-dependent hepatotoxic effects.
    Solter PF; Wollenberg GK; Huang X; Chu FS; Runnegar MT
    Toxicol Sci; 1998 Jul; 44(1):87-96. PubMed ID: 9720145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic ultrastructural changes induced by the toxin microcystin-LR (MCLR) in mice.
    Hermansky SJ; Markin RS; Fowler EH; Stohs SJ
    J Environ Pathol Toxicol Oncol; 1993; 12(2):101-6. PubMed ID: 8189358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased hepatic ALT synthesis is an outcome of subchronic microcystin-LR toxicity.
    Solter P; Liu Z; Guzman R
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):216-20. PubMed ID: 10764635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel monoclonal antibodies against microcystin and their protective activity for hepatotoxicity.
    Nagata S; Soutome H; Tsutsumi T; Hasegawa A; Sekijima M; Sugamata M; Harada K; Suganuma M; Ueno Y
    Nat Toxins; 1995; 3(2):78-86. PubMed ID: 7613739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of microcystin-protein phosphatase adduct formation with immunochemical methods.
    Liu BH; Yu FY; Huang X; Chu FS
    Toxicon; 2000 May; 38(5):619-32. PubMed ID: 10673155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of intraperitoneal doses of microcystin-LR in two strains of male mice.
    Lovell RA; Schaeffer DJ; Hooser SB; Haschek WM; Dahlem AM; Carmichael WW; Beasley VR
    J Environ Pathol Toxicol Oncol; 1989; 9(3):221-37. PubMed ID: 2509678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic response indicators of microcystin-LR in F344 rats following a single-dose treatment.
    Billam M; Mukhi S; Tang L; Gao W; Wang JS
    Toxicon; 2008 May; 51(6):1068-80. PubMed ID: 18339415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.